ARWR
Price
$16.81
Change
+$0.35 (+2.13%)
Updated
Jun 6 closing price
Capitalization
2.27B
65 days until earnings call
BEAM
Price
$18.57
Change
+$1.58 (+9.29%)
Updated
Jun 6 closing price
Capitalization
1.71B
66 days until earnings call
Interact to see
Advertisement

ARWR vs BEAM

Header iconARWR vs BEAM Comparison
Open Charts ARWR vs BEAMBanner chart's image
Arrowhead Pharmaceuticals
Price$16.81
Change+$0.35 (+2.13%)
Volume$1.24M
Capitalization2.27B
Beam Therapeutics
Price$18.57
Change+$1.58 (+9.29%)
Volume$3.9M
Capitalization1.71B
ARWR vs BEAM Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. BEAM commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Buy and BEAM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ARWR: $15.56 vs. BEAM: $16.88)
Brand notoriety: ARWR: Notable vs. BEAM: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 82% vs. BEAM: 60%
Market capitalization -- ARWR: $2.27B vs. BEAM: $1.71B
ARWR [@Biotechnology] is valued at $2.27B. BEAM’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, ARWR is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 5 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ARWR’s TA Score: 5 bullish, 4 bearish.
  • BEAM’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ARWR.

Price Growth

ARWR (@Biotechnology) experienced а +1.63% price change this week, while BEAM (@Biotechnology) price change was -1.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.27B) has a higher market cap than BEAM($1.71B). ARWR YTD gains are higher at: -17.234 vs. BEAM (-31.935). BEAM has higher annual earnings (EBITDA): -383.98M vs. ARWR (-580.69M). BEAM has more cash in the bank: 851M vs. ARWR (553M). BEAM has less debt than ARWR: BEAM (161M) vs ARWR (525M). BEAM has higher revenues than ARWR: BEAM (63.5M) vs ARWR (2.5M).
ARWRBEAMARWR / BEAM
Capitalization2.27B1.71B133%
EBITDA-580.69M-383.98M151%
Gain YTD-17.234-31.93554%
P/E RatioN/AN/A-
Revenue2.5M63.5M4%
Total Cash553M851M65%
Total Debt525M161M326%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRBEAM
RSI
ODDS (%)
Bearish Trend 11 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
85%
Momentum
ODDS (%)
Bullish Trend 11 days ago
67%
Bearish Trend 11 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 11 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
73%
Bearish Trend 11 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 23 days ago
79%
Declines
ODDS (%)
Bearish Trend about 1 month ago
84%
Bearish Trend 25 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
82%
Bullish Trend 11 days ago
90%
Aroon
ODDS (%)
Bullish Trend 11 days ago
67%
Bullish Trend 11 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+1.24%
DNLI - ARWR
58%
Loosely correlated
-1.29%
NTLA - ARWR
57%
Loosely correlated
+3.59%
BEAM - ARWR
54%
Loosely correlated
-0.88%
RGNX - ARWR
54%
Loosely correlated
-5.84%
IMNM - ARWR
53%
Loosely correlated
+0.35%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-0.88%
CRSP - BEAM
71%
Closely correlated
-0.92%
NTLA - BEAM
66%
Loosely correlated
+3.59%
RXRX - BEAM
63%
Loosely correlated
+0.11%
DNLI - BEAM
61%
Loosely correlated
-1.29%
VERV - BEAM
59%
Loosely correlated
-1.17%
More